These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 141906)

  • 1. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
    Maeda H; Sakamoto S; Ogata J
    Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and excretion of neocarzinostatin (NCS) in mice after oral administration.
    Toriyama K; Fujita H; Ishida N
    J Antibiot (Tokyo); 1975 Jan; 28(1):64-72. PubMed ID: 123896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical investigations of neocarzinostatin in Japan.
    Kimura I
    Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of neocarzinostatin entrapped in liposomes.
    Shinozawa S; Araki Y; Oda T
    Gan; 1980 Feb; 71(1):107-11. PubMed ID: 6445846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.
    Comis RL; Griffin TW; Raso V; Ginsberg SJ
    Cancer Res; 1979 Mar; 39(3):757-61. PubMed ID: 154969
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of two-route chemotherapy using intraperitoneal neocarzinostatin and its antidote, intravenous tiopronin, for peritoneally disseminated tumors in mice.
    Hasuda K; Kobayashi H; Kuroiwa T; Aoki K; Taniguchi S; Baba T
    Jpn J Cancer Res; 1989 Mar; 80(3):283-9. PubMed ID: 2524462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of intralymphatic chemotherapy in rabbits].
    Satomi A; Takada Y; Ishida K
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2262-8. PubMed ID: 2955746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of the anticancer polypeptide neocarzinostatin.
    Hall SW; Knight J; Broughton A; Benjamin RS; McKelvey E
    Cancer Chemother Pharmacol; 1983; 10(3):200-4. PubMed ID: 6222845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
    Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
    J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Part I. Theory and computer simulation for cerebrospinal infusion].
    Maeda H; Matsukado Y; Iwai Z; Uemura S; Kuratsu J; Takeshita J; Sano Y
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1040-5. PubMed ID: 6223592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
    Sakamoto S; Maeda H; Ogata J
    Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer.
    Sakamoto S; Ogata J; Ikegami K; Maeda H
    Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neocarzinostatin therapy of advanced renal cell carcinoma].
    Tari K; Satake I; Kojima S; Tsujii T; Yonese J
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.
    Maeda H; Sano Y; Takeshita J; Iwai Z; Kosaka H; Marubayashi T; Matsukado Y
    Cancer Chemother Pharmacol; 1981; 5(4):243-9. PubMed ID: 6455212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promoting effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancer tissue.
    Nakazawa I; Ouchi E; Ishida N; Takano S; Ouchi K; Wagai K
    Tohoku J Exp Med; 1980 May; 131(1):101-2. PubMed ID: 6447386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.
    Maeda H; Takeshita J; Yamashita A
    Eur J Cancer (1965); 1980 May; 16(5):723-31. PubMed ID: 6446456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for antagonistic agents to the lethal toxicity of neocarzinostatin. II. Effects of various drugs in inhibiting the toxicity of neocarzinostatin in vivo].
    Ouchi M; Toriyama K; Matsumoto T; Baba T
    Jpn J Antibiot; 1988 Jan; 41(1):105-15. PubMed ID: 2966869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
    Takeshita J; Maeda H; Kanamaru R
    Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancerous tissues.
    Nakazawa I; Ouchi E; Ishida N; Ouchi K; Wagai K
    Tohoku J Exp Med; 1978 Jan; 124(1):97-8. PubMed ID: 147527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.